Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PF-07220060 Plus Letrozole in Neoadjuvant HR+/HER2- Breast Cancer
NCT06465368Phase 2Completed
- Sponsor
- Pfizer
- Start
- Jul 2024
- Primary completion
- Jul 2025
- Modality
- Small Molecules
- Countries
- 13
01
Overview
A Phase 2 trial of atirmociclib in breast cancer, sponsored by Pfizer. Started Jul 2024; status: completed.
02
Drugs
atirmociclib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT06465368.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06465368.